StonvexLoading…
StonvexStonvexStonvexCore line items from SBFM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $36.31M | $34.87M | $24.09M | $4.35M |
Operating Income | $-6.23M | $-5.81M | $-4.79M | $-27.00M |
Net Income | $-5.98M | $-5.13M | $-4.51M | $-26.74M |
EPS (Diluted) | $-1.44 | $-7.32 | $-351.36 | $-1.76 |
Total Assets | $30.08M | $30.56M | $27.35M | $29.24M |
Total Liabilities | $7.04M | $7.06M | $6.14M | $7.62M |
Cash & Equivalents | $9.12M | $9.69M | $16.29M | $21.83M |
Free Cash Flow OCF − CapEx | $-5.51M | $-14.18M | $-8.86M | $-5.44M |
Shares Outstanding | 4.91M | 2.58M | 14.01K | 22.59M |